Geron Corp. (GERN)
1.235
-0.06
(-4.26%)
USD |
NASDAQ |
May 18, 16:00
1.24
0.00 (0.00%)
After-Hours: 19:35
Geron Research and Development Expense (Quarterly) : 14.96M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 210.17M |
| ACADIA Pharmaceuticals, Inc. | 76.87M |
| BioMarin Pharmaceutical, Inc. | 178.80M |
| Insmed, Inc. | 209.48M |
| MannKind Corp. | 17.23M |